Last edition
News about "US FDA Establishment Inspection Report"
Symbiotec Pharmalab Receives VAI Status from US FDA
Symbiotec Pharmalab has received a US FDA Establishment Inspection Report with VAI classification for its Pithampur facility following an August 2026 inspection.
US FDA Establishment Inspection Report | 29/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members